Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
18B Fraunhoferstrasse, Planegg, , 82152, DE
Coriolis Pharma is a global contract research and development organization (CRDO) and the premier partner for the development of liquid and lyophilized drug products, analytical services, and manufacturing services across a vast array of therapeutic modalities, including biologics, gene and cell therapies and vaccines. Our scientists design and execute platform and custom services to accelerate and de-risk your program right from the start and throughout the entire product lifecycle.
Suarez will lead the execution of the company’s $50 billion U.S. research, development and manufacturing investment.
By: Charlie Sternberg
Pitcher offers experience scaling cell and gene therapy manufacturing operations and aligning them with client and patient needs.
The program aims to expedite the development of technologies and life-changing therapies for patients in need.
Will offer clients end-to-end solutions from early formulation through to commercial manufacturing.
AGC Biologics to provide GMP manufacturing for AAVantgarde’s two novel candidates designed to address progressive and irreversible vision loss.
Expands the company’s nationwide network supporting cell and gene therapy (CGT) innovation.
The certification highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain.
Plans to use the Chapter 11 process to explore strategic alternatives, safeguard its assets, and ensure equitable treatment of its creditors.
Addresses gene therapy production challenges.
Launches new GMP-grade cytokines and AAV medium.
Will build a center for Cell and Gene Therapy (CGT) development and manufacturing near Bangkok, in Thailand.
Capitol Biologics will provide process development, early-phase clinical manufacturing, and analytical services to emerging biotechnology companies and U.S. government agencies.
Will leverage Andelyn’s suspension AAV Curator platform to provide scalable manufacturing of clinical-grade AAV material.
Avista will leverage Forge’s FUEL platform to manufacture AAV for AVST-101, Avista’s lead gene therapy to treat patients with X-linked retinoschisis (XLRS).
By: Rachel Klemovitch
The new facility designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
